Transcriptional regulation of the BCL-6 gene

Mechanistic dissection using mutant cell lines

Gang Zhou, Santa Jeremy Ono

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Mice lacking the BCL-6 gene product exhibit overexpression of T helper cell type 2 cytokines, and multi-organ inflammatory responses characterized by eosinophilia and infiltration by IgE+ B lymphocytes. Elevated IgE levels appear to result from loss of BCL-6's role in repression of the Stat6-dependent processes of I- epsilon transcription and IgE class-switching. Understanding the regulation of the BCL-6 gene expression is therefore relevant to the allergic response, due to the IgE-dependent activation of mast cells and basophils. Materials and Methods: We analyzed a pair of isogenic cell lines that exhibit differential expression of the BCL-6 gene and mapped the control point to transcription using nuclear run-on assays. Direct analyses of the BCL-6 gene and transfection experiments were carried out to map the molecular basis for the differential expression. Results: In this study, we report that pair of isogenic cell lines exhibits differential expression of BCL-6. BCL-6 mRNA is barely detectable in Jijoye, a Burkitt lymphoma B cell line, but is abundant in Clone-13, a mutant cell line derived from Jijoye. Corresponding to the mRNA level, BCL-6 protein is detected only in Clone-13, but not in Jijoye. Nuclear run-on assays indicate that BCL-6 expression is regulated mainly at the transcriptional level in these two cell lines. Gene structural alterations are not detected in a region including a 3-kb promoter and the first intron, where most of the chromosomal translocations are observed in diffuse large cell lymphoma (DLCL). Interestingly, multiple, heterozygous point mutations are identified in the first intron, the hypermutation region of BCL-6, in both of the two cell lines. However, in transient transfection experiments these mutations have no effects on gene expression. Conclusions: Our data suggest that the distinct profile of BCL-6 expression in Jijoye/Clone-13 is due to either a missing negative element in a different portion of the gene or that there is an issue of chromatin accessibility operating in BCL-6 gene regulation. This pair of isogenic cell lines (Jijoye/Clone-13) thus provides a new system to dissect the regulation of BCL-6 gene expression.

Original languageEnglish (US)
Pages (from-to)645-654
Number of pages10
JournalMolecular Medicine
Volume8
Issue number10
StatePublished - Oct 1 2002
Externally publishedYes

Fingerprint

Dissection
Cell Line
Immunoglobulin E
Genes
Clone Cells
Gene Expression
Introns
Transfection
B-Lymphocytes
Immunoglobulin Class Switching
Th2 Cells
Genetic Translocation
Messenger RNA
Burkitt Lymphoma
Basophils
Lymphoma, Large B-Cell, Diffuse
Eosinophilia
Point Mutation
Mast Cells
Chromatin

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Transcriptional regulation of the BCL-6 gene : Mechanistic dissection using mutant cell lines. / Zhou, Gang; Ono, Santa Jeremy.

In: Molecular Medicine, Vol. 8, No. 10, 01.10.2002, p. 645-654.

Research output: Contribution to journalArticle

@article{cb605904ae6149b58a73f4310f4a32e2,
title = "Transcriptional regulation of the BCL-6 gene: Mechanistic dissection using mutant cell lines",
abstract = "Background: Mice lacking the BCL-6 gene product exhibit overexpression of T helper cell type 2 cytokines, and multi-organ inflammatory responses characterized by eosinophilia and infiltration by IgE+ B lymphocytes. Elevated IgE levels appear to result from loss of BCL-6's role in repression of the Stat6-dependent processes of I- epsilon transcription and IgE class-switching. Understanding the regulation of the BCL-6 gene expression is therefore relevant to the allergic response, due to the IgE-dependent activation of mast cells and basophils. Materials and Methods: We analyzed a pair of isogenic cell lines that exhibit differential expression of the BCL-6 gene and mapped the control point to transcription using nuclear run-on assays. Direct analyses of the BCL-6 gene and transfection experiments were carried out to map the molecular basis for the differential expression. Results: In this study, we report that pair of isogenic cell lines exhibits differential expression of BCL-6. BCL-6 mRNA is barely detectable in Jijoye, a Burkitt lymphoma B cell line, but is abundant in Clone-13, a mutant cell line derived from Jijoye. Corresponding to the mRNA level, BCL-6 protein is detected only in Clone-13, but not in Jijoye. Nuclear run-on assays indicate that BCL-6 expression is regulated mainly at the transcriptional level in these two cell lines. Gene structural alterations are not detected in a region including a 3-kb promoter and the first intron, where most of the chromosomal translocations are observed in diffuse large cell lymphoma (DLCL). Interestingly, multiple, heterozygous point mutations are identified in the first intron, the hypermutation region of BCL-6, in both of the two cell lines. However, in transient transfection experiments these mutations have no effects on gene expression. Conclusions: Our data suggest that the distinct profile of BCL-6 expression in Jijoye/Clone-13 is due to either a missing negative element in a different portion of the gene or that there is an issue of chromatin accessibility operating in BCL-6 gene regulation. This pair of isogenic cell lines (Jijoye/Clone-13) thus provides a new system to dissect the regulation of BCL-6 gene expression.",
author = "Gang Zhou and Ono, {Santa Jeremy}",
year = "2002",
month = "10",
day = "1",
language = "English (US)",
volume = "8",
pages = "645--654",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "10",

}

TY - JOUR

T1 - Transcriptional regulation of the BCL-6 gene

T2 - Mechanistic dissection using mutant cell lines

AU - Zhou, Gang

AU - Ono, Santa Jeremy

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Background: Mice lacking the BCL-6 gene product exhibit overexpression of T helper cell type 2 cytokines, and multi-organ inflammatory responses characterized by eosinophilia and infiltration by IgE+ B lymphocytes. Elevated IgE levels appear to result from loss of BCL-6's role in repression of the Stat6-dependent processes of I- epsilon transcription and IgE class-switching. Understanding the regulation of the BCL-6 gene expression is therefore relevant to the allergic response, due to the IgE-dependent activation of mast cells and basophils. Materials and Methods: We analyzed a pair of isogenic cell lines that exhibit differential expression of the BCL-6 gene and mapped the control point to transcription using nuclear run-on assays. Direct analyses of the BCL-6 gene and transfection experiments were carried out to map the molecular basis for the differential expression. Results: In this study, we report that pair of isogenic cell lines exhibits differential expression of BCL-6. BCL-6 mRNA is barely detectable in Jijoye, a Burkitt lymphoma B cell line, but is abundant in Clone-13, a mutant cell line derived from Jijoye. Corresponding to the mRNA level, BCL-6 protein is detected only in Clone-13, but not in Jijoye. Nuclear run-on assays indicate that BCL-6 expression is regulated mainly at the transcriptional level in these two cell lines. Gene structural alterations are not detected in a region including a 3-kb promoter and the first intron, where most of the chromosomal translocations are observed in diffuse large cell lymphoma (DLCL). Interestingly, multiple, heterozygous point mutations are identified in the first intron, the hypermutation region of BCL-6, in both of the two cell lines. However, in transient transfection experiments these mutations have no effects on gene expression. Conclusions: Our data suggest that the distinct profile of BCL-6 expression in Jijoye/Clone-13 is due to either a missing negative element in a different portion of the gene or that there is an issue of chromatin accessibility operating in BCL-6 gene regulation. This pair of isogenic cell lines (Jijoye/Clone-13) thus provides a new system to dissect the regulation of BCL-6 gene expression.

AB - Background: Mice lacking the BCL-6 gene product exhibit overexpression of T helper cell type 2 cytokines, and multi-organ inflammatory responses characterized by eosinophilia and infiltration by IgE+ B lymphocytes. Elevated IgE levels appear to result from loss of BCL-6's role in repression of the Stat6-dependent processes of I- epsilon transcription and IgE class-switching. Understanding the regulation of the BCL-6 gene expression is therefore relevant to the allergic response, due to the IgE-dependent activation of mast cells and basophils. Materials and Methods: We analyzed a pair of isogenic cell lines that exhibit differential expression of the BCL-6 gene and mapped the control point to transcription using nuclear run-on assays. Direct analyses of the BCL-6 gene and transfection experiments were carried out to map the molecular basis for the differential expression. Results: In this study, we report that pair of isogenic cell lines exhibits differential expression of BCL-6. BCL-6 mRNA is barely detectable in Jijoye, a Burkitt lymphoma B cell line, but is abundant in Clone-13, a mutant cell line derived from Jijoye. Corresponding to the mRNA level, BCL-6 protein is detected only in Clone-13, but not in Jijoye. Nuclear run-on assays indicate that BCL-6 expression is regulated mainly at the transcriptional level in these two cell lines. Gene structural alterations are not detected in a region including a 3-kb promoter and the first intron, where most of the chromosomal translocations are observed in diffuse large cell lymphoma (DLCL). Interestingly, multiple, heterozygous point mutations are identified in the first intron, the hypermutation region of BCL-6, in both of the two cell lines. However, in transient transfection experiments these mutations have no effects on gene expression. Conclusions: Our data suggest that the distinct profile of BCL-6 expression in Jijoye/Clone-13 is due to either a missing negative element in a different portion of the gene or that there is an issue of chromatin accessibility operating in BCL-6 gene regulation. This pair of isogenic cell lines (Jijoye/Clone-13) thus provides a new system to dissect the regulation of BCL-6 gene expression.

UR - http://www.scopus.com/inward/record.url?scp=0036821238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036821238&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 645

EP - 654

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 10

ER -